Moleculin Biotech Inc. (NASDAQ: MBRX) Stock Information | RedChip

Moleculin Biotech Inc. (NASDAQ: MBRX) Listen to this Section


$2.42
+0.1850 ( +8.30% ) 76.9K

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The company's lead program, Annamycin is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Market Data


Open


$2.42

Previous close


$2.23

Volume


76.9K

Market cap


$6.25M

Day range


$1.48 - $2.44

52 week range


$1.48 - $15.75

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 16 Sep 14, 2023
def Proxies and info statements 3 Sep 01, 2023
8-k/a 8K-related 34 Aug 23, 2023
8-k 8K-related 15 Aug 21, 2023
pre Proxies and info statements 3 Aug 21, 2023
8-k 8K-related 34 Aug 21, 2023
8-k 8K-related 16 Aug 11, 2023
8-k 8K-related 16 Aug 10, 2023
10-q Quarterly Reports 49 Aug 10, 2023
8-k 8K-related 16 Aug 07, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.